Cargando…

Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets

Aminoglycosides, amikacin (AK) and kanamycin (KM) are second line anti-tuberculosis drugs used to treat tuberculosis (TB) and resistance to them affects the treatment. Membrane and membrane associated proteins have an anticipated role in biological processes and pathogenesis and are potential target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Divakar, Kumar, Bhavnesh, Lata, Manju, Joshi, Beenu, Venkatesan, Krishnamurthy, Shukla, Sangeeta, Bisht, Deepa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593609/ https://www.ncbi.nlm.nih.gov/pubmed/26436944 http://dx.doi.org/10.1371/journal.pone.0139414

Ejemplares similares

Culture filtrate proteome analysis of aminoglycoside resistant clinical isolates of Mycobacterium tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2014)

Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS
por: Sharma, Divakar, et al.
Publicado: (2016)

Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis
por: Sharma, Prashant, et al.
Publicado: (2010)

Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates
por: Singhal, Neelja, et al.
Publicado: (2012)

Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis
por: Venkatesan, Arunkumar, et al.
Publicado: (2016)

Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect
por: Sharma, Divakar, et al.
Publicado: (2018)

M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
por: Sharma, Divakar, et al.
Publicado: (2017)

Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach
por: Sharma, Divakar, et al.
Publicado: (2017)

Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant
por: Singh, Amit, et al.
Publicado: (2015)

A simple and rapid method of sample preparation from culture filtrate of M. tuberculosis for two-dimensional gel electrophoresis
por: Kumar, Gavish, et al.
Publicado: (2010)

Insights into Mycobacterium leprae Proteomics and Biomarkers—An Overview
por: Gautam, Sakshi, et al.
Publicado: (2021)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Resistome analysis of Mycobacterium tuberculosis: Identification of aminoglycoside 2'-Nacetyltransferase (AAC) as co-target for drug desigining
por: Joshi, Rakesh S, et al.
Publicado: (2013)

IL-10 down-regulates the expression of survival associated gene hspX of Mycobacterium tuberculosis in murine macrophage
por: Jee, Babban, et al.
Publicado: (2017)

A Random Sequential Mechanism of Aminoglycoside Acetylation by Mycobacterium tuberculosis Eis Protein
por: Tsodikov, Oleg V., et al.
Publicado: (2014)

Whole-genome sequencing and transcriptome-characterized in vitro evolution of aminoglycoside resistance in Mycobacterium tuberculosis
por: Wei, Wenjing, et al.
Publicado: (2023)

Mycobacterium tuberculosis secretory proteins downregulate T cell activation by interfering with proximal and downstream T cell signalling events
por: Sharma, Bhawna, et al.
Publicado: (2015)

Phytofabrication of Silver nanoparticles: Novel Drug to overcome hepatocellular ailments
por: Singh, Asha, et al.
Publicado: (2018)

Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met
por: Gupta, Vivek Kumar, et al.
Publicado: (2017)

Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates
por: Singh, Mradula, et al.
Publicado: (2011)

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
por: Sharma, Sandeep, et al.
Publicado: (2022)

TOWARDS ELIMINATION OF STIGMA & UNTOUCHABILITY: A Case for Leprosy
por: Patil, Shripad, et al.
Publicado: (2019)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
por: Swain, Shasank S., et al.
Publicado: (2020)

Structural Annotation of Mycobacterium tuberculosis Proteome
por: Anand, Praveen, et al.
Publicado: (2011)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
por: Kalokhe, Ameeta S., et al.
Publicado: (2012)

Bioenergetic State of Escherichia coli Controls Aminoglycoside Susceptibility
por: El Khoury, Jessica Y., et al.
Publicado: (2023)

Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis
por: Prasad, Thottethodi Subrahmanya Keshava, et al.
Publicado: (2013)

A High-Throughput Cidality Screen for Mycobacterium Tuberculosis
por: Kaur, Parvinder, et al.
Publicado: (2015)

Exploring modulations in T-cell receptor-mediated T-cell signaling events in systemic circulation and at local disease site of patients with tubercular pleural effusion: An attempt to understand tuberculosis pathogenesis at the local disease site
por: Sharma, Bhawna, et al.
Publicado: (2022)

Whole cell & culture filtrate proteins from prevalent genotypes of Mycobacterium tuberculosis provoke better antibody & T cell response than laboratory strain H(37)Rv
por: Kumar, Gavish, et al.
Publicado: (2012)

Aminoglycoside Therapy for Tuberculosis: Evidence for Ototoxicity among Tuberculosis Patients in Ghana
por: Owusu, Enid, et al.
Publicado: (2022)

Proteomic analysis of drug-susceptible and multidrug-resistant nonreplicating Beijing strains of Mycobacterium tuberculosis cultured in vitro
por: Saiboonjan, Bhanubong, et al.
Publicado: (2021)

Serodiagnostic Efficacy of Mycobacterium tuberculosis 30/32-kDa Mycolyl Transferase Complex, ESAT-6, and CFP-10 in Patients with Active Tuberculosis
por: Kumar, Gavish, et al.
Publicado: (2010)

Proteome Analysis of the Plasma Membrane of Mycobacterium Tuberculosis
por: Sinha, Sudhir, et al.
Publicado: (2002)

Proteomic Definition of the Cell Wall of Mycobacterium tuberculosis
por: Wolfe, Lisa M., et al.
Publicado: (2010)

Deciphering the Proteomic Landscape of Mycobacterium tuberculosis in Response to Acid and Oxidative Stresses
por: Choudhary, Eira, et al.
Publicado: (2022)

Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis
por: Ayelign, Birhanu, et al.
Publicado: (2019)

Stable Susceptibility to Aminoglycosides in an Age of Low Level, Institutional Use
por: Bosso, John A., et al.
Publicado: (2013)

Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis
por: Maurya, Rahul Kumar, et al.
Publicado: (2019)

Adhesion molecules facilitate host-pathogen interaction & mediate Mycobacterium tuberculosis pathogenesis
por: Bisht, Durga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0j6cg3fhgjb6un58aqsecst0qg